Stock listing
Frankfurt:51B Bioventix PLC Aktie
German listing (Frankfurt) of Bioventix PLC · home listing LSE:BVXP
Follow Bioventix PLC into a list and get an email when it puts out news.
Share price · FWB:51B
€22.40 EUR -0.20 (-0.9%)
Close on Nov 20, 2026
- Day range
- €22.40 – €23.80 EURNov 20, 2026
- Market cap
- €117.0M EURAt the close on Nov 20, 2026 · price × 5.22M shares outstanding
- 52-week range
- €15.02 – €23.80 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- €257 EURMedian day 0 shares · 52 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| LSE:BVXP · Home | 1,950.00p GBX (pence) | 0.00 (0.0%) | 9,892 | 1,950.00p | 1,995.00p | 1,850.00p | 1,950.00p | Close on Nov 20, 2026 |
| Frankfurt:51B | €22.40 EUR | -0.20 (-0.9%) | — | €22.40 | €23.80 | €22.40 | €22.60 | Close on Nov 20, 2026 |
| Stuttgart:51B | €22.40 EUR | 0.00 (0.0%) | — | €22.40 | €22.60 | €22.40 | €22.40 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 6, 2026 · FWB:51B · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €22.51 | -0.734 | -3.2% | €22.58 | €22.67 | €22.51 | 0 | |
| €23.24 | -0.497 | -2.1% | €23.24 | €23.24 | €23.24 | 0 | |
| €23.74 | +0.124 | +0.5% | €23.74 | €23.74 | €23.74 | 0 | |
| €23.61 | -0.001 | 0.0% | €23.61 | €23.61 | €23.61 | 0 | |
| €23.61 | +0.45 | +1.9% | €23.43 | €23.80 | €23.41 | 0 | |
| €23.16 | -0.57 | -2.4% | €23.17 | €23.18 | €22.98 | 0 | |
| €23.73 | +0.706 | +3.1% | €23.73 | €23.73 | €23.73 | 0 | |
| €23.03 | +0.291 | +1.3% | €23.03 | €23.03 | €23.03 | 0 | |
| €22.74 | -0.432 | -1.9% | €22.74 | €22.74 | €22.74 | 0 | |
| €23.17 | +0.227 | +1.0% | €23.17 | €23.17 | €23.17 | 0 | |
| €22.94 | +2.863 | +14.3% | €22.94 | €22.94 | €22.94 | 0 | |
| €20.08 | -1.99 | -9.0% | €22.36 | €22.39 | €20.01 | 108 | |
| €22.07 | -0.533 | -2.4% | €22.07 | €22.07 | €22.07 | 0 | |
| €22.60 | +2.223 | +10.9% | €20.05 | €22.66 | €20.04 | 172 | |
| €20.38 | +0.042 | +0.2% | €20.42 | €20.48 | €20.03 | 50 | |
| €20.34 | +0.448 | +2.3% | €19.92 | €20.50 | €19.61 | 0 | |
| €19.89 | +1.059 | +5.6% | €19.89 | €19.89 | €19.89 | 0 | |
| €18.83 | -2.061 | -9.9% | €18.83 | €18.83 | €18.83 | 0 | |
| €20.89 | +0.278 | +1.3% | €20.58 | €21.02 | €20.57 | 200 | |
| €20.61 | +1.005 | +5.1% | €20.65 | €20.70 | €20.59 | 0 | |
| €19.61 | +0.017 | +0.1% | €19.61 | €19.61 | €19.61 | 0 | |
| €19.59 | +0.057 | +0.3% | €19.59 | €19.59 | €19.59 | 0 | |
| €19.53 | +0.675 | +3.6% | €19.53 | €19.53 | €19.53 | 0 | |
| €18.86 | +0.037 | +0.2% | €18.86 | €18.86 | €18.86 | 0 | |
| €18.82 | -0.021 | -0.1% | €18.79 | €18.83 | €18.77 | 0 | |
| €18.84 | -1.04 | -5.2% | €18.58 | €18.95 | €18.43 | 0 | |
| €19.88 | -0.718 | -3.5% | €19.88 | €19.88 | €19.88 | 0 | |
| €20.60 | +2.215 | +12.0% | €18.56 | €20.63 | €18.46 | 165 | |
| €18.39 | +0.125 | +0.7% | €18.39 | €18.39 | €18.39 | 0 | |
| €18.26 | +0.716 | +4.1% | €17.71 | €18.27 | €17.69 | 0 | |
| €17.54 | +0.48 | +2.8% | €17.27 | €17.56 | €17.26 | 0 | |
| €17.06 | -0.206 | -1.2% | €17.06 | €17.06 | €17.06 | 0 | |
| €17.27 | +0.12 | +0.7% | €17.28 | €17.28 | €17.16 | 0 | |
| €17.15 | -0.485 | -2.8% | €17.64 | €17.84 | €17.03 | 0 | |
| €17.64 | +0.563 | +3.3% | €17.26 | €17.69 | €17.16 | 0 | |
| €17.07 | +0.436 | +2.6% | €16.74 | €17.12 | €16.72 | 0 | |
| €16.64 | -0.146 | -0.9% | €16.75 | €16.75 | €16.47 | 0 | |
| €16.78 | +0.198 | +1.2% | €16.72 | €16.80 | €16.46 | 0 | |
| €16.58 | -0.303 | -1.8% | €16.61 | €16.61 | €16.54 | 0 | |
| €16.89 | -0.751 | -4.3% | €17.63 | €17.72 | €16.77 | 0 | |
| €17.64 | +0.546 | +3.2% | €16.98 | €17.73 | €16.93 | 0 | |
| €17.09 | -1.027 | -5.7% | €18.08 | €18.13 | €17.05 | 0 | |
| €18.12 | -0.793 | -4.2% | €18.97 | €19.07 | €18.06 | 0 | |
| €18.91 | +0.082 | +0.4% | €18.91 | €18.91 | €18.91 | 0 | |
| €18.83 | -0.182 | -1.0% | €18.83 | €18.83 | €18.83 | 0 | |
| €19.01 | -0.141 | -0.7% | €19.04 | €19.10 | €19.01 | 0 | |
| €19.15 | -0.013 | -0.1% | €19.15 | €19.15 | €19.15 | 0 | |
| €19.17 | -0.104 | -0.5% | €19.17 | €19.17 | €19.17 | 0 | |
| €19.27 | -0.117 | -0.6% | €19.27 | €19.27 | €19.27 | 0 | |
| €19.39 | -0.067 | -0.3% | €19.39 | €19.39 | €19.39 | 0 | |
| €19.45 | +0.266 | +1.4% | €19.45 | €19.45 | €19.45 | 0 | |
| €19.19 | -0.546 | -2.8% | €19.31 | €19.32 | €19.12 | 0 | |
| €19.73 | +0.177 | +0.9% | €19.73 | €19.73 | €19.73 | 0 | |
| €19.56 | +0.033 | +0.2% | €19.56 | €19.56 | €19.56 | 0 | |
| €19.52 | -0.12 | -0.6% | €19.52 | €19.52 | €19.52 | 0 | |
| €19.64 | +1.065 | +5.7% | €20.13 | €20.30 | €19.63 | 0 | |
| €18.58 | +1.02 | +5.8% | €18.58 | €18.58 | €18.58 | 0 |
- Ticker
- Frankfurt:51B
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Nov 6, 2026
Posting of Annual Report and Notice of AGM
Latest deck · October 2026
FY2026 Earnings Presentation
Earnings · 26 slides
Latest news
Posting of Annual Report and Notice of AGM
Nov 6, 2026
Closed €22.51 (-3.2%) on Nov 6, 2026
Holding(s) in Company
Oct 30, 2026
Closed €23.61 (+1.9%) on Nov 2, 2026
Results for the year ended 30 June 2026
Oct 26, 2026
Closed €23.17 (+1.0%) on Oct 26, 2026
Share Options Awarded
Apr 20, 2026
Closed €19.92 (+1.5%) on Apr 20, 2026
Appointment of Non-Executive Director
Feb 24, 2026
Closed €17.82 (+0.2%) on Feb 24, 2026
Result of AGM
Dec 4, 2025
Closed €21.01 (+3.0%) on Dec 5, 2025
Director Dealing
Nov 26, 2025
Closed €22.04 (-2.4%) on Nov 26, 2025
Bioventix PLC on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 8 in the last 12 months · 65 in all · newest Nov 6, 2026 · oldest 2010
- Decks
- 13 decks · latest October 2026
Where Bioventix PLC is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| LSE:BVXP · Home listing | LSE | United Kingdom | GBX |
| LS Exchange:A113DD | LS Exchange | Germany | EUR |
| Lang & Schwarz:A113DD | Lang & Schwarz | Germany | EUR |
| AQUIS:BVXP.GB | AQUIS | United Kingdom | GBX |
| Dusseldorf:51B | Dusseldorf | Germany | EUR |
| Frankfurt:51B · This page | Frankfurt | Germany | EUR |
| gettex:51B | gettex | Germany | EUR |
| Stuttgart:51B | Stuttgart | Germany | EUR |
| OTC:BVNXF | OTC | United States | USD |
Valuation
P/E 13.4× against a median of 35.6×: 2nd lowest of 5 Diagnostics & research services companies shown. Statements: Year to Jun 30, 2025 · balance Dec 31, 2025 · price Nov 20, 2026
- Enterprise value
- £96.58M GBP
- P/E
- 13.4×
- EV/sales
- 7.4×
- EV/EBITDA
- 9.7×
- Price/book
- 9.2×
- Gross margin
- 90.9%
- Operating margin
- 75.5%
- Net margin
- 57.8%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Bioventix PLC · LSE:BVXP | US$133.3M | US$126.3M | 13.4× | 7.4× | 9.7× | 9.2× | 57.8% | 0.0× | n/a |
| Genovis AB · OMXSTO:GENO | US$150.1M | US$142.7M | 74.9× | 10.8× | 41.7× | 5.0× | 15.1% | 0.3× | n/a |
| Genomictree, Inc. · KRX:228760 | US$148.6M | US$89.43M | n/a | 40.6× | n/a | 1.6× | −306.4% | 0.0× | n/a |
| Anbio Biotechnology · NASDAQ:NNNN | US$145.7M | US$133.8M | 22.8× | 15.5× | n/a | 4.8× | 74.1% | 0.0× | 0.56 |
| MaxCyte, Inc. · NASDAQ:MXCT | US$141.5M | US$57.06M | n/a | 1.7× | n/a | 0.9× | −81.4% | 0.1× | 0.93 |
| Shanghai Rightongene Biotechnology Co. Ltd. Class A · SSE:688217 | US$139.0M | US$102.4M | n/a | 4.6× | n/a | 1.1× | −43.9% | 0.0× | n/a |
| EKF Diagnostics Holdings plc · LSE:EKF | US$134.4M | US$115.4M | 48.4× | 1.7× | 7.1× | 1.5× | 4.1% | 0.0× | n/a |
| Curiosis, Inc. · KRX:494120 | US$131.9M | US$118.3M | n/a | 18.7× | n/a | 7.1× | −93.3% | 0.0× | n/a |
| Bioneer Corporation · KRX:064550 | US$128.3M | US$107.8M | n/a | 0.4× | 10.0× | 0.8× | −1.9% | 0.3× | n/a |
| Fine Foods & Pharmaceuticals N.T.M. SpA · MIL:FF | US$123.5M | US$174.6M | 11.1× | 0.6× | 4.6× | 0.8× | 4.0% | 0.6× | n/a |
| Burning Rock Biotech Ltd. · NASDAQ:BNR | US$116.7M | US$60.66M | n/a | 0.8× | n/a | 1.6× | −13.6% | 0.1× | 1.51 |
| Median of the others | US$136.7M | US$111.6M | 35.6× | 3.2× | 8.6× | 1.5× | −7.8% | 0.1× | 0.93 |
Forecasts
Analysts' consensus from EODHD, read Nov 19, 2026. Not 6ix's view and not investment advice.
- Price target
- 3900.00 GBX · Analysts' mean
- EPS, year to Jun 2027
- 1.43 · 1 analyst
- Revenue, year to Jun 2027
- 12.96M · 1 analyst
Team and board
Officers
| Officer | Role |
|---|---|
| Peter Harrison | Chief Executive Officer |
| Bruce Hiscock | Chief Financial Officer |
Board
| Director | Role |
|---|---|
| Ian Nicholson | Chairman and Independent Non-Executive Director |
| Bruce Hiscock | Chief Financial Officer |
| Chris Yates | Independent Non-Executive Director |
| Jo Pisani | Independent Non-Executive Director |
| Peter Harrison | Chief Executive Officer |
Events
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Sep 30, 2025 | Nov 11, 2025 | 0.0% |
| Q2 2025 | Mar 31, 2025 | −11.8% |
| Q2 2023 | Mar 27, 2023 · Before open | +7.9% |
| Quarter to Sep 30, 2022 | Oct 24, 2022 · After close | −1.5% |
| Q2 2022 | Mar 30, 2022 | +7.2% |
| Q1 2022 | Oct 18, 2021 | −0.6% |
| Q2 2021 | Mar 29, 2021 | +2.6% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| FY2026 Earnings Presentation | Earnings | 26 slides | October 2026 |
| Investor Presentation (March 2026) | Investor deck | 15 slides | Mar 30, 2026 |
| Investor Presentation (October 2025) | Investor deck | 15 slides | Oct 27, 2025 |
| Investor Presentation (March 2025) | Investor deck | 16 slides | Mar 31, 2025 |
| Investor Presentation (October 2024) | Investor deck | 19 slides | Oct 28, 2024 |
| Investor Presentation (March 2024) | Investor deck | 15 slides | Mar 25, 2024 |
| Investor Presentation (October 2023) | Investor deck | 19 slides | Oct 30, 2023 |
| Investor Presentation (March 2023) | Investor deck | 16 slides | Mar 27, 2023 |
| Investor Presentation (March 2023) | Investor deck | 15 slides | Mar 27, 2023 |
| Investor Presentation (October 2022) | Investor deck | 15 slides | Oct 24, 2022 |
All 13 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (March 2022) | Investor deck | 11 slides | Mar 28, 2022 |
| Investor Presentation (March 2021) | Investor deck | 11 slides | Mar 29, 2021 |
| Investor Presentation (October 2019) | Investor deck | 15 slides | October 2019 |
Financials
Annual, in GBP
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 13.1M | 13.6M | 12.8M | 11.7M | 10.9M | 10.3M | 9.29M | 8.75M | 7.25M | 5.52M |
| Cost of revenue | 1.20M | 925.5K | 957.6K | 853.8K | 952.6K | 955.4K | 875.1K | 573.2K | 494.9K | 494.9K |
| Gross profit | 11.9M | 12.7M | 11.9M | 10.9M | 9.98M | 9.36M | 8.41M | 8.18M | 6.75M | 5.02M |
| Research and development | 1.49M | 999.4K | 1.20M | 975.3K | 1.20M | 1.18M | 1.12M | 868.5K | 764.5K | 713.7K |
| Selling, general and administrative | 2.05M | 1.99M | 1.77M | 1.61M | 1.51M | 1.42M | 1.27M | 1.18M | 998.8K | 839.2K |
| Operating income | 9.90M | 10.6M | 10.0M | 9.27M | 8.09M | 7.96M | 7.03M | 6.90M | 5.71M | 4.13M |
| Depreciation and amortization | 92.8K | 113.6K | 129.2K | 143.4K | 135.1K | 133.6K | 67.5K | 58.5K | 39.5K | 41.7K |
| EBITDA | 10.00M | 10.7M | 10.2M | 9.42M | 8.22M | 8.09M | 7.10M | 6.96M | 5.75M | 4.17M |
| Interest expense | 0 | 303 | 263.4K | 243.7K | 0 | 15 | 0 | 164 | ||
| Income before tax | 10.1M | 10.6M | 10.1M | 9.26M | 8.09M | 8.20M | 6.97M | 6.87M | 5.77M | 4.22M |
| Income tax | 2.51M | 2.48M | 1.74M | 1.60M | 1.39M | 1.00M | 1.10M | 1.20M | 849.6K | 724.5K |
| Net income | 7.58M | 8.10M | 8.37M | 7.67M | 6.73M | 7.20M | 5.86M | 5.66M | 4.92M | 3.49M |
| Earnings per share, basic | 1.43 | 1.53 | 1.58 | 1.46 | 1.28 | 1.38 | 1.12 | 1.08 | 0.95 | 0.68 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 5.08M | 6.00M | 5.72M | 6.13M | 6.49M | 8.08M | 6.54M | 6.99M | 6.17M | 5.38M |
| Receivables | 6.24M | 6.21M | 5.81M | 5.22M | 4.63M | 3.65M | 3.93M | 3.82M | 3.34M | 435.6K |
| Inventory | 689.4K | 615.3K | 565.4K | 461.8K | 332.5K | 245.4K | 239.3K | 283.1K | 226.2K | 198.9K |
| Current assets | 12.0M | 12.8M | 12.1M | 11.8M | 11.5M | 12.0M | 10.7M | 11.1M | 9.74M | 8.26M |
| Property, plant and equipment | 694.4K | 843.7K | 718.5K | 514.8K | 497.8K | 449.3K | 467.1K | |||
| Goodwill | 0 | 0 | ||||||||
| Total assets | 12.9M | 13.7M | 13.3M | 13.1M | 12.9M | 13.3M | 11.6M | 11.9M | 10.4M | 8.78M |
| Accounts payable | 77.9K | 170.0K | 77.7K | 157.3K | 150.9K | 96.1K | 25.3K | 20.6K | 23.3K | 22.1K |
| Current liabilities | 1.31M | 1.73M | 1.20M | 1.25M | 1.01M | 728.6K | 756.6K | 838.4K | 219.9K | 549.9K |
| Total liabilities | 1.31M | 1.73M | 1.22M | 1.30M | 1.09M | 778.9K | 787.4K | 864.7K | 236.1K | 567.9K |
| Shareholders' equity | 11.6M | 12.0M | 12.1M | 11.8M | 11.8M | 12.5M | 10.8M | 11.0M | 10.1M | 8.21M |
| Shares outstanding | 5.29M | 5.30M | 5.29M | 5.26M | 5.26M | 5.22M | 5.23M | 5.23M | 5.20M | 5.14M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 7.03M | 8.34M | 7.90M | 7.56M | 6.37M | 7.72M | 5.88M | 5.92M | 3.96M | 3.17M |
| Capital spending | -19.2K | -15.9K | -10.6K | -11.8K | -260.3K | -339.6K | -84.5K | -107.6K | -21.7K | -21.0K |
| Free cash flow | 7.01M | 8.33M | 7.89M | 7.55M | 6.11M | 7.38M | 5.79M | 5.81M | 3.94M | 3.15M |
| Cash from investing | 173.2K | 186.1K | 90.5K | -11.8K | -259.8K | -561.3K | -146.8K | -169.4K | -118.4K | 2.58K |
| Cash from financing | -8.12M | -8.25M | -8.30M | -7.92M | -7.69M | -5.62M | -6.18M | -4.93M | -3.05M | -1.92M |
| Dividends paid | -8.19M | -8.25M | -8.44M | -7.92M | -7.71M | -6.50M | -6.22M | -4.93M | -3.37M | -1.92M |
| Share buybacks | 20.2K | 879.7K | 41.0K | 321.1K | 321.1K | |||||
| Change in cash | -919.7K | 283.1K | -410.8K | -368.3K | -1.58M | 1.54M | -449.2K | 819.6K | 786.5K | 1.25M |
Cap table
Built by 6ix from Bioventix PLC’s releases
- Common shares
- 5,224,860
- Fully diluted
- 5,224,860
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 5,224,860 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 5,224,860 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Bruce Hiscock | Chief Financial Officer · Since at least Apr 20, 2026 |
| Chris Yates | Independent Non-Executive Director · Since at least Feb 24, 2026 |
| Ian Nicholson | Chairman and Independent Non-Executive Director · Since at least Nov 5, 2026 |
| Jo Pisani | Independent Non-Executive Director · Since at least Nov 5, 2026 |
| Peter Harrison | Chief Executive Officer · Since at least Oct 26, 2026 |
Log in to ask 6ix AI your own questions about Bioventix PLC.